Functional characterization and pharmacochaperone rescue of a novel SLC6A1 variant associated with developmental epileptic encephalopathies
Researchers have utilized both AI predictive tools and experimental assays to characterize a novel SLC6A1 gene mutation linked to neurodevelopmental disorders like epilepsy and autism. The study demonstrates that pharmacochaperones can potentially rescue the function of the mutated protein.
Why it matters
This research provides a framework for using AI to accelerate the understanding of genetic mutations, offering potential pathways for future therapeutic interventions in rare diseases.
Scientific Reports ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in